Use of a novel implantable cardioverter‐defibrillator multisensor algorithm for heart failure monitoring in a COVID‐19 patient: A case report

Bontempi, Luca; Cerini, Manuel; Salghetti, Francesca; Fabbricatore, Davide; Nozza, Clara; Campari, Monica; Valsecchi, Sergio; Curnis, Antonio

doi:10.1002/ccr3.3721

Cited by 2 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 18 Numerous individual case studies with HeartLogic capable devices and SARS‐CoV‐2 infections have also suggested that individual sensors may help identify patients who are COVID‐19 positive, even before patients themselves report symptoms. 19 , 20 , 21 , 22 The sensor changes reported in these individual cases are consistent with the quantitative trends that we report here, including increasing respiratory rate and impedance.…”

Section: Discussionsupporting

confidence: 89%

Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection

et al. 2021

View full text Add to dashboard Cite

Aims Implantable device‐based sensor measurements including heart sounds, markers of ventilation, and thoracic impedance have been shown to predict heart failure (HF) hospitalizations. We sought to assess how these parameters changed prior to COVID‐19 (Cov‐19) and how these compared with those presenting with decompensated HF or pneumonia. Methods and results This retrospective analysis explores patterns of changes in daily measurements by implantable sensors in 10 patients with Cov‐19 and compares these findings with those observed prior to HF ( n = 88) and pneumonia ( n = 12) hospitalizations from the MultiSENSE, PREEMPT‐HF, and MANAGE‐HF trials. The earliest sensor changes prior to Cov‐19 were observed in respiratory rate (6 days) and temperature (5 days). There was a three‐fold to four‐fold greater increase in respiratory rate, rapid shallow breathing index, and night heart rate compared with those presenting with HF or pneumonia. Furthermore, activity levels fell more in those presenting with Cov‐19, a change that was often sustained for some time. In contrast, there were no significant changes in 1st or 3rd heart sound (S 1 and S 3 ) amplitude in those presenting with Cov‐19 or pneumonia compared with the known changes that occur in HF decompensation. Conclusions Multi‐sensor device diagnostics may provide early detection of Cov‐19, distinguishable from worsening HF by an extreme and fast rise in respiratory rate along with no changes in S3.

show abstract

Section: Discussionsupporting

confidence: 89%

Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection

et al. 2021

View full text Add to dashboard Cite

show abstract

“…From our review of the literature, we found two case reports 8 , 9 and 2 case series 10 , 11 reporting the HL physiologic sensor changes, for a total of eight patients with SARS‐CoV‐2 infection. As represented in Table 1 , the patients were all infected by SARS‐CoV‐2 and even though only 3/8 patients had a more severe clinical manifestation with pneumonia, in 8/8 patients (100%) an increase in the ITI in association with an increase in the RR and a decrease in the activity level was present.…”

Section: Case Reportmentioning

confidence: 99%

A reproducible sensor pattern to suspect COVID19 pulmonary infection with LATITUDE. Case report and literature review

Zanchi

Greca

Nanni

et al. 2022

Pacing Clinical Electrophis

View full text Add to dashboard Cite

A 78 year-old patient with postischaemic dilated cardiomyopathy and severely reduced ejection fraction was implanted with a Boston Scientific RESONATE X4 CRT-D and followed by LATITUDE remote monitoring platform. From the end of January to the end of March 2021 he was hospitalized for COVID19 pneumonia followed by two episodes of acute heart decompensation with bilateral pleural effusion. We remotely followed the patient and identified a typical Heart Logic sensor pattern linked to the COVID19 pneumonia, different from the one linked to the heart failure (HF). We eventually made a literature review on the topic.

show abstract

Use of a novel implantable cardioverter‐defibrillator multisensor algorithm for heart failure monitoring in a COVID‐19 patient: A case report

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Cited by 2 publications

References 14 publications

Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection

Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection

A reproducible sensor pattern to suspect COVID19 pulmonary infection with LATITUDE. Case report and literature review

Contact Info

Product

Resources

About